4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole → 2-(2-(1H-indazol-4-yl)-9-methyl-6-morpholino-9H-purin-8-yl)propan-2-ol
반응식
[CH3:22][C:23]1([CH3:24])[C:25]([CH3:26])([CH3:27])[O:28][B:29]([c:30]2[c:31]3[cH:32][n:33][nH:34][c:35]3[cH:36][cH:37][cH:38]2)[O:39]1.[Cl:1][c:2]1[n:3][c:4]([N:16]2[CH2:17][CH2:18][O:19][CH2:20][CH2:21]2)[c:5]2[n:6][c:7]([C:12]([CH3:13])([CH3:14])[OH:15])[n:8]([CH3:11])[c:9]2[n:10]1>>[c:2]1(-[c:30]2[c:31]3[cH:32][n:33][nH:34][c:35]3[cH:36][cH:37][cH:38]2)[n:3][c:4]([N:16]2[CH2:17][CH2:18][O:19][CH2:20][CH2:21]2)[c:5]2[n:6][c:7]([C:12]([CH3:13])([CH3:14])[OH:15])[n:8]([CH3:11])[c:9]2[n:10]1참가 물질
3
출처 및 근거
- ORD 기록
- ord-225efcbabd704ad1a921bff566205b8f
- 출처 데이터셋
- Training data from https://doi.org/10.1039/C8SC04228D (2/10)
반응 노트
불러오는 중…